Approval sought for clinical trial of combination of Covaccine and Covishield vaccines

New Delhi: An expert committee of the Central Drugs Authority of India on Thursday recommended that the Christian Medical College (CMC), Vellore, be given a mix of two COVID-19 vaccines, Covaccine and Covishield. Clinical trials should be allowed. Official sources have given this information.

The source said that the purpose of the study is to find out whether two different doses of vaccine can be administered for a complete vaccination of a person i.e. one vaccine should be given with Covaccine and the other vaccine should be given with Covishield.< /p>

The expert group also discussed the application made by Biological-E to conduct Phase II/III clinical trials of its COVID-19 vaccine on a population aged five to 17 years.

7242 new cases of corona reported in Maharashtra today, restrictions can be relaxed in 25 districts including Mumbai


Leave a Comment

Your email address will not be published. Required fields are marked *